Physician profile
Audrey M Wohl
NPI 1154749166
$4,136.02
in general payments reported to CMS, 2019-2025
29 companies · $805 in 2025
The $805 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $661 · 2022: $749 · 2023: $997 · 2024: $923 · 2025: $805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,725.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,320.52 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $435.26 | 2021-2024 | Senza |
| Medtronic, INC. | $373.65 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Osteocool Rf Ablation System |
| Tersera Therapeutics LLC | $241.73 | 2022-2025 | Prialt |
| Astrazeneca Pharmaceuticals LP | $236.38 | 2021-2022 | |
| Abbott Laboratories | $201.84 | 2022-2023 | Proclaim |
| Averitas Pharma INC. | $162.24 | 2023-2025 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $134.10 | 2022-2025 | Zilretta, Iovera, Exparel |
| Regeneron Healthcare Solutions, INC. | $121.82 | 2023 | Dupixent |
| Vertex Pharmaceuticals Incorporated | $97.54 | 2024-2025 | |
| Spr Therapeutics, INC | $97.36 | 2022-2025 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $93.40 | 2021-2023 | Ztlido |
| Nalu Medical, INC. | $85.87 | 2021-2022 | |
| Genentech USA, INC. | $84.17 | 2021 | |
| Saluda Medical Americas, INC. | $78.56 | 2024-2025 | Evoke |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $61.49 | 2022 | |
| Avanos Medical | $42.69 | 2023 | Coolief* Cooled Radiofrequency, Generator |
| Ipsen Biopharmaceuticals, INC | $36.94 | 2022-2023 | Dysport |
| Kyowa Kirin, INC. | $31.94 | 2024-2025 | Crysvita |
| Trevena, INC. | $27.86 | 2021 | |
| Relievant Medsystems, INC. | $25.53 | 2022 | |
| Biotronik Nro, INC. | $23.48 | 2025 | Prospera |
| Lundbeck LLC | $22.48 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $21.90 | 2023 | Seglentis |
| Painteq LLC | $20.31 | 2023 | Painteq |
| Grt US Holding, INC. | $17.75 | 2022 | |
| Convatec INC. | $15.18 | 2024 | |
| Horizon Therapeutics Plc | $12.89 | 2021 | |
| Almatica Pharma LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Wohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.